References
- DrummondMFSculpherMJTorranceGWO’BrienBJStoddartGLMethods for the Economic Evaluation of Health Care Programmes3rd edNew YorkOxford University Press2005
- National Institute for Health and Care Excellence (NICE)Guide to the Methods of Technology AppraisalLondon2013
- PapaioannouDBrazierJPaisleySNice dsu technical support document 9: the identification, review and synthesis of health state utility values from the literatureUniversity of ShefflieldSheffield2011
- KnottRAuNHollingsworthBLorgellyPAnchoring vignettes and measures of health: adjusting for systematic differences in reporting behaviour10th World Congress in Health Economics for the International Health Economics Association (iHEA)July 12–16, 2014Dublin, Ireland
- BaileyHKindPPreliminary findings of an investigation into the relationship between national culture and EQ-5D value setsQual life Res20101981145115420496167
- AugestadLARand-HendriksenKKristiansenISStavemKImpact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value setsPharmacoeconomics201230121203121423116290
- KniesSEversSMAACandelMJJMSeverensJLAmentAJHAUtilities of the EQ-5D: transferable or not?Pharmacoeconomics200927976777919757870
- SzendeAOppeMDevlinNEQ-5D Value Sets: Inventory, Comparative Review and User GuideThe EuroQol Group2007Dordrecht, the Netherlands
- OppongRKaambwaBNuttallJHoodKSmithRDCoastJThe impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countriesEur J Heal Econ2013142197209
- BadiaXRosetMHerdmanMKindPA comparison of United Kingdom and spanish general population time trade-off values for eq-5d health statesMed Decis Mak2001211716
- BarbieriMDrummondMRuttenFWhat do international pharmacoeconomic guidelines say about economic data transferability?Value Health20101381028103720667054
- WelteRFeenstraTJagerHLeidlRA decision chart for assessing and improving the transferability of economic evaluation results between countriesPharmacoeconomics2004221385787615329031
- KarlssonJANilssonJ-ÅNeoviusMNational EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patientsAnn Rheum Dis201170122163216621859684
- ParkinDRiceNDevlinNStatistical analysis of EQ-5D profiles: does the use of value sets bias inference?Med Decis Mak2010305556565
- ChuangLZarateVKindPEstimating domestic values for eq-5d health states using survey data from external sourcesMed Care200947216817519169117
- DolanPModeling valuations for EuroQol health statesMed Care19973511109511089366889
- LamersLMMcdonnellJStalmeierPFMKrabbePFMBusschbachJJVThe Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studiesHealth Econ2006151121113216786549
- GreinerWClaesCBusschbachJJVSchulenburg J-M. Validating the EQ-5D with time trade off for the German populationEur J Heal Econ200562124130
- OddershedeLAndreasenJJEhlersLEstimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgeryClin Outcomes Res2014612127
- OddershedeLWalkerSPatonNStöhrWDunnDSculpherMJCost-effectiveness analysis of protease inhibitor monotherapy vs ongoing triple-therapy in the long-term management of HIV patientsValue Health2014177A683
- UdsenFWLilholtPHHejlesenOEhlersLHEffectiveness and cost-effectiveness of telehealthcare for chronic obstructive pulmonary disease: study protocol for a cluster randomized controlled trialTrials20141517824886225
- PetersenKDKronborgCGyrd-HansenDDahlRLarsenJNLinnebergACharacteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?Eur J Public Health201121332332820484343
- HvidbergMFBrinthLSOlesenAVPetersenKDEhlersLThe health-related quality of life for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)PLoS One2015107e013242126147503
- SørensenSSPedersenKMWeinreichUMEhlersLHDesign, and participant enrollment, of a randomized controlled trial evaluating effectiveness and cost-effectiveness of a community-based case management intervention, for patients suffering from COPDOpen Access J Clin Trials201575362